Skip to main content
. 2023 Nov 30;22(2):232–252. doi: 10.9758/cpn.23.1119

Table 3.

Relative effects table

Amisulpride 0.01
(−1.68, 1.73)
−1.13
(−3.27, 1.02)
0.14
(−1.99, 2.31)
0.15
(−1.97, 2.30)
0.43
(−1.70, 2.61)
0.13
(−2.34, 2.67)
0.02
(−1.49, 1.58)
−1.74
(−3.95, 0.46)
−0.19
(−2.32, 2.00)
−4.83
(−7.53,
−2.08)
−0.42
(−2.55, 1.77)
1.06
(−0.65, 2.82)
0.36
(−0.73, 1.48)
0.45
(−1.40, 2.30)
−0.06
(−1.41, 1.29)
0.13
(−2.05, 2.29)
−0.46
(−2.62, 1.70)
−0.06
(−2.20, 2.11)
−0.38
(−2.14, 1.38)
Aripiprazole −1.14
(−3.43, 1.10)
0.13
(−2.15, 2.40)
0.14
(−2.12, 2.43)
0.42
(−1.86, 2.68)
0.12
(−1.71, 1.99)
0.01
(−1.67, 1.71)
−1.75
(−4.10, 0.55)
−0.20
(−2.46, 2.06)
−4.84
(−7.66,
−2.04)
−0.42
(−2.71, 1.85)
1.05
(−0.79, 2.93)
0.35
(−0.97, 1.65)
0.44
(−2.08, 2.97)
−0.06
(−1.60, 1.43)
0.11
(−2.17, 2.41)
−0.48
(−2.77, 1.81)
−0.06
(−2.33, 2.18)
−0.40
(−2.31, 1.50)
Duloxetine 1.28
(−1.31, 3.86)
1.30
(−1.31, 3.91)
1.58
(−1.05, 4.18)
1.27
(−1.59, 4.19)
1.16
(−0.95, 3.27)
−0.61
(−3.25, 2.05)
0.95
(−1.66, 3.56)
−3.69
(−6.80,
−0.61)
0.72
(−1.90, 3.33)
2.19
(−0.04, 4.50)
1.49
(−0.33, 3.34)
1.59
(−1.24, 4.40)
1.07
(−0.90, 3.06)
1.26
(−1.36, 3.94)
0.67
(−1.94, 3.29)
1.07
(−1.52, 3.68)
0.74
(−1.55, 3.08)
Fluvoxamine 0.01
(−2.56, 2.61)
0.29 (−2.31, 2.90) 0.00
(−2.90, 2.89)
−0.12 (−2.23, 2.02) −1.90 (−4.54, 0.76) −0.34
(−2.92, 2.27)
−4.97
(−8.05,
−1.86)
−0.56
(−3.17, 2.07)
0.92
(−1.32, 3.19)
0.21
(−1.63, 2.06)
0.31
(−2.51, 3.12)
−0.20
(−2.18, 1.78)
−0.01
(−2.64, 2.59)
−0.61
(−3.21, 2.01)
−0.20
(−2.83, 2.41)
−0.52
(−2.85, 1.78)
Ginkgo Biloba 0.27
(−2.31, 2.89)
−0.02
(−2.93, 2.91)
−0.13
(−2.25, 1.98)
−1.90
(−4.56, 0.76)
−0.35
(−2.94, 2.24)
−4.99
(−8.10,
−1.87)
−0.57
(−3.18, 2.05)
0.91
(−1.35, 3.16)
0.20
(−1.63, 2.04)
0.29
(−2.53, 3.11)
−0.22
(−2.23, 1.78)
−0.03
(−2.68, 2.59)
−0.62
(−3.24, 1.97)
−0.22
(−2.81, 2.36)
−0.53
(−2.83, 1.75)
Glycine −0.29
(−3.21, 2.62)
−0.41
(−2.52, 1.73)
−2.18
(−4.85, 0.48)
−0.63
(−3.21, 1.98)
−5.27
(−8.31,
−2.15)
−0.85
(−3.48, 1.75)
0.62
(−1.62, 2.92)
−0.07
(−1.89, 1.78)
0.02
(−2.85, 2.82)
−0.49
(−2.49, 1.52)
−0.30
(−2.95, 2.32)
−0.90
(−3.49, 1.73)
−0.49
(−3.10, 2.12)
−0.82
(−3.14, 1.49)
Haloperidol −0.11
(−2.60, 2.37)
−1.88 (−4.86, 1.10) −0.33
(−3.23, 2.60)
−4.96
(−8.33,
−1.59)
−0.56
(−3.50, 2.36)
0.92
(−1.67, 3.54)
0.22
(−2.04, 2.46)
0.31
(−2.83, 3.41)
−0.19
(−2.60, 2.16)
−0.01
(−2.93, 2.89)
−0.60
(−3.54, 2.33)
−0.19
(−3.15, 2.69)
−0.52
(−3.19, 2.11)
Lamotrigine −1.77
(−3.96, 0.43)
−0.21
(−2.34, 1.90)
−4.85
(−7.52,
−2.13)
−0.44
(−2.58, 1.71)
1.03
(−0.63, 2.75)
0.33
(−0.73, 1.39)
0.43 (−2.01, 2.82) −0.08
(−1.40, 1.22)
0.10
(−2.05, 2.27)
−0.48
(−2.63, 1.64)
−0.08
(−2.24, 2.03)
−0.41
(−2.17, 1.34)
Memantine 1.55
(−1.09, 4.21)
−3.08
(−6.24, 0.05)
1.32
(−1.36, 4.01)
2.81 (0.49, 5.16) 2.10 (0.18, 4.03) 2.20
(−0.71, 5.10)
1.68
(−0.39, 3.79)
1.87
(−0.81, 4.51)
1.28
(−1.42, 3.94)
1.68
(−0.98, 4.32)
1.36
(−1.00, 3.73)
Minocycline −4.64
(−7.71,
−1.52)
−0.23
(−2.82, 2.38)
1.25
(−0.98, 3.51)
0.54
(−1.27, 2.39)
0.64
(−2.20, 3.49)
0.12
(−1.86, 2.13)
0.31
(−2.33, 2.96)
−0.28
(−2.85, 2.32)
0.12
(−2.49, 2.72)
−0.20
(−2.53, 2.12)
Mirtazapine 4.42 (1.27, 7.47) 5.89 (3.08, 8.72) 5.19 (2.69, 7.66) 5.28 (1.96, 8.57) 4.76 (2.14, 7.35) 4.96 (1.82, 8.08) 4.36 (1.23, 7.42) 4.77 (1.65, 7.82) 4.44 (1.58, 7.26)
NaBenzoate 1.48
(−0.781, 3.75)
0.78
(−1.07, 2.62)
0.87
(−2.02, 3.71)
0.35
(−1.68, 2.34)
0.54
(−2.10, 3.16)
−0.05
(−2.67, 2.57)
0.36
(−2.27, 2.99)
0.02
(−2.30, 2.346)
Pimozide −0.70 (−2.03, 0.60) −0.60 (−3.20, 1.91) −1.13 (−2.67, 0.40) −0.94 (−3.24, 1.35) −1.53 (−3.81, 0.74) −1.13 (−3.42, 1.14) −1.45 (−3.38, 0.44)
Placebo 0.09 (−2.09, 2.27) −0.42 (−1.21, 0.35) −0.23 (−2.11, 1.63) −0.83 (−2.69, 1.01) −0.42 (−2.26, 1.41) −0.74 (−2.13, 0.64)
Quetiapine −0.51 (−2.83, 1.78) −0.32 (−3.16, 2.52) −0.92 (−3.77, 1.97) −0.52 (−3.41, 2.36) −0.84 (−3.41, 1.73)
Risperidone 0.18 (−1.86, 2.22) −0.40 (−2.41, 1.60) 0.00 (−2.01, 2.00) −0.32 (−1.70, 1.07)
Sarcosine −0.59 (−3.22, 2.05) −0.18 (−2.85, 2.46) −0.51 (−2.87, 1.83)
Sulpiride 0.40 (−2.19, 3.05) 0.08 (−2.23, 2.40)
Topiramate −0.32 (−2.62, 2.00)
Ziprasidone

Values are presented as standardized mean difference (95% credible interval).

Comparison of column-specific intervention with row-specific interventions.